We recently added Revere Data LLC as an Alacra content partner. Revere Data publishes Revere Research Reports, indispensable sources of valuable information and analysis on topics
ranging from healthcare events, competitor overviews, product pipeline analysis,
supplier analysis and thousands of merger and acquisition scenarios. All Revere
reports are powered by the Revere Hierarchy™ and most include a rich array of other Revere content sources,
such as Revere Relationships™ and Revere Products™. On Alacra Premium and the Alacra Store you can now purchase:
Company Profile Reports which offer a view of a company's business, including products and services, major competitors, customers, partners and partners along with key financial data.
Competitors by Product Reports which provide a product-by-product analysis of a company's exact competitors, with trade names for each product.
Biotech Pipeline Risk Report which features biotech companies with a ratio of opportunity to risk based on a diversified late-stage drug portfolio.
Drug/Medical Device Report which contains a complete description of a biopharmaceutical or medical device company's product line along with indications, side effects and regulatory/clinical stage.
FDA Approval Decisions Report which tracks drugs with expected FDA approval dates (commonly known as PDUFA dates) in the next three months.
We’re excited to provide access to Revere’s comprehensive research on a transactional basis, making it available to a greater audience of users. In addition, in the first quarter of this year, Alacra will be adding the capability to dynamically generate merger and acquisitions (M&A) reports based on input of buyer and target as well as offer the option to select pre-generated M&A reports.
To learn more about the Revere Research Reports, or view a sample, visit their Alacra Partner page or subscribe to their RSS feed on the Alacra Store. [Posted by Allison Rowley, Alacra Project Manager]







Congrats on this launch Steve. Good stuff.
Posted by: p-air | January 04, 2007 at 01:28 PM